Market Tracker

05/26 5:16pm ET

Acorda Therapeutics Inc (NASDAQ:ACOR)

14.25
Delayed Data
As of May 26
 -0.30 / -2.06%
Today’s Change
14.15
Today|||52-Week Range
33.00
-24.20%
Year-to-Date

Today’s Trading

Previous close14.55
Today’s open14.50
Day’s range14.15 - 14.60
Volume893,044
Average volume (3 months)1,049,390
Market cap$678.9M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-404.00%
Earnings growth (this year)+693.14%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+5.47%
P/E ratioNM
Price/Sales1.64
Price/Book1.00

Competitors

 Today’s
change
Today’s
% change
AMPHAmphastar Pharmaceut...+1.50+9.70%
OMEROmeros Corp-0.14-0.88%
ACRSAclaris Therapeutics...-0.40-1.59%
CYTKCytokinetics Inc+0.05+0.36%
Data as of 4:00pm ET, 05/26/2017

Financials

Next reporting dateAugust 3, 2017
EPS forecast (this quarter)$0.49
Annual revenue (last year)$519.6M
Annual profit (last year)-$34.6M
Net profit margin-6.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Financial &
Accounting Officer
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts